Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2018, Article ID 9720823, 3 pages
https://doi.org/10.1155/2018/9720823
Case Report

Relapsing Malaria: A Case Report of Primaquine Resistance

1Northeast Ohio Medical University, Rootstown, OH, USA
2Elmhurst Hospital Center, Elmhurst, NY, USA
3Mount Sinai School of Medicine, New York, NY, USA
4Kent State University, Kent, OH, USA

Correspondence should be addressed to Sunita Shakya; ude.tnek@2aykahss

Received 15 December 2017; Accepted 22 February 2018; Published 11 March 2018

Academic Editor: Stephen Patrick Kachur

Copyright © 2018 Christopher Dijanic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. K. Baird, “Evidence and implications of mortality associated with acute Plasmodium vivax malaria,” Clinical Microbiology Reviews, vol. 26, no. 1, pp. 36–57, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. R. J. H. Ingram, C. Crenna-Darusallam, S. Soebianto, R. Noviyanti, and J. Baird, “The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea,” Malaria Journal, vol. 13, no. 1, p. 488, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. K. E. Battle, M. S. Karhunen, S. Bhatt et al., “Geographical variation in Plasmodium vivax relapse,” Malaria Journal, vol. 13, no. 1, p. 144, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. R. E. Howes, K. E. Battle, K. N. Mendis et al., “Global epidemiology of Plasmodium vivax,” American Journal of Tropical Medicine and Hygiene, vol. 95, no. 6, pp. 15–34, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. S. R. Marcsisin, G. Reichard, and B. S. Pybus, “Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: current state of the art,” Pharmacology and Therapeutics, vol. 161, pp. 1–10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. S.-F. Zhou, “Polymorphism of human cytochrome P450 2D6 and its clinical significance,” Clinical Pharmacokinetics, vol. 48, no. 12, pp. 761–804, 2009. View at Publisher · View at Google Scholar · View at Scopus